Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
08/1999
08/17/1999US5939298 Isolated polynucleotide segment having amino acid sequence homology to a known haemophilus influenzae phenylalanyl trna synthetase (alpha-subunit)protein; can be used to screen for antibacterial compounds
08/17/1999US5939297 Hybrid protein
08/17/1999US5939286 Hybrid interferon tau/alpha polypeptides, their recombinant production, and methods using them
08/17/1999US5939277 Detection and treatment of breast and gynecological cancer
08/17/1999US5939075 Mutants of Brucella melitensis
08/17/1999US5939074 Polypeptides; useful for prodcution of vaccine against hiv infection and diagnosis
08/17/1999US5939073 Fish pancreatic disease virus
08/17/1999US5939072 Combination of mushroom derived polysaccharides derived from at least two types of mushrooms selected from maitake, shiitake, reishi, poria, cordyceps and hericium; treating hepatitis
08/17/1999US5939068 Neutralizing high affinity human monoclonal antibodies specific to RSV F-protein and methods for their manufacture and therapeutic use thereof
08/17/1999US5939067 Gonococcal anti-idiotypic antibodies and methods and compositions using them
08/17/1999US5939066 Treating or preventing a bacterial infection by administering a lactamase inhibitory effective amount of a penem and a lactam antibiotic
08/17/1999US5939064 Bordetella bronchiseptica vaccine
08/17/1999US5939050 Antimicrobial compositions
08/17/1999CA2147594C Procedure for the obtainment of 1-(5-bromofur-2-il)-2-bromo-2-nitroethene and its microcide action
08/12/1999WO1999040201A1 Protein
08/12/1999WO1999040200A1 RECOMBINANT LIPIDATED PsaA PROTEIN, METHODS OF PREPARATION AND USE
08/12/1999WO1999040184A1 Dendritic enriched secreted lymphocyte activation molecule
08/12/1999WO1999040183A1 Human serine protease and serpin polypeptides
08/12/1999WO1999040108A1 New compound
08/12/1999WO1999040094A1 Agent for sealing metallic ground coats, especially ground coats consisting of zinc or zinc alloys
08/12/1999WO1999040091A1 Bicyclic pyridine and pyrimidine derivatives as neuropeptide y receptor antagonists
08/12/1999WO1999040089A1 Benzothiadiazoles and derivatives
08/12/1999WO1999040080A1 Hydroxamic and carboxylic acid derivatives
08/12/1999WO1999040061A2 Novel dihydroxyhexanoic acid derivatives
08/12/1999WO1999039735A1 Live vaccine for human immunodeficiency virus
08/12/1999WO1999039733A1 Delivery method for recombinant raccoon poxvirus
08/12/1999WO1999039732A1 Pharmaceutical compositions comprising peg-asparaginase for the treatment of hiv infections
08/12/1999WO1999039704A1 Antibacterial agents
08/12/1999WO1999039691A2 Pharmaceutical compositions
08/12/1999WO1999039582A1 Proteins encoded by polynucleic acids of porcine reproductive and respiratory syndrome virus (prrsv)
08/12/1999WO1999027955A3 Treatment of established chronic infections and cancers
08/12/1999WO1999026940A3 Method for producing 8-methoxy-quinoline carboxylic acids
08/12/1999WO1999026666A3 Medical article with adhered antimicrobial metal
08/12/1999WO1999025378A9 Immunoglobulin molecules having a synthetic variable region and modified specificity
08/12/1999WO1999022761A9 Conjugate heat shock protein-binding peptides
08/12/1999WO1999003446A3 Antimicrobial cosmetic compositions
08/12/1999DE19805117A1 Neue Oxazolidinone mit azolhaltigen Tricyclen Novel oxazolidinones with azole tricycles
08/12/1999DE19801265C1 Inhibierung von CD95-unabhängiger Apoptose bei AIDS Inhibiting CD95-independent apoptosis in AIDS
08/12/1999CA2751655A1 Proteins encoded by polynucleic acids of porcine reproductive and respiratory syndrome virus (prrsv)
08/12/1999CA2320489A1 Live vaccine for human immunodeficiency virus
08/12/1999CA2320476A1 Antibacterial agents
08/12/1999CA2320416A1 New compound
08/12/1999CA2320359A1 Proteins encoded by polynucleic acids of porcine reproductive and respiratory syndrome virus (prrsv)
08/12/1999CA2319644A1 Human serine protease and serpin polypeptides
08/12/1999CA2319356A1 Composition and methods for treatment of hiv infection
08/12/1999CA2319097A1 Dendritic enriched secreted lymphocyte activation molecule
08/12/1999CA2318977A1 Derivatives of benzoxadiazoles, benzothiadiazoles, benzotriazoles and quinoxalines
08/12/1999CA2317476A1 Hydroxamic and carboxylic acid derivatives
08/11/1999EP0934944A1 7-bromo- and 7,7-dibromo-cepham and cephem derivatives and their use as protease inhibitors
08/11/1999EP0934942A1 Novel beta-lactam compounds and process for preparing the same
08/11/1999EP0934939A1 Neuraminic acid compounds
08/11/1999EP0934747A1 Reverse transcriptase inhibitor from Ulmus Hollandica
08/11/1999EP0934531A1 Diagnosis of spongiform encephalopathy
08/11/1999EP0934416A1 Feline polynucleotide vaccine formula
08/11/1999EP0934403A1 Embryonic or stem-like cell lines produced by cross species nuclear transplantation
08/11/1999EP0934335A1 Novel compounds
08/11/1999EP0934333A1 Unique associated kaposi's sarcoma virus sequences and uses thereof
08/11/1999EP0934331A2 Mirror-symmetrical selection and evolution of nucleic acids
08/11/1999EP0934318A1 Novel 3, 5, and/or 6 substituted analogues of swainsonine, processes for their preparation and their use as therapeutic agents
08/11/1999EP0934317A2 Novel 6 or 7 substituted analogues of swainsonine, processes for their preparation and their use as therapeutic agents
08/11/1999EP0934316A1 Azabicyclic carbamoyloxy mutilin derivatives for antibacterial use
08/11/1999EP0934300A1 The preparation and use of ortho-sulfonamido heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors
08/11/1999EP0934262A1 Beta-thiopropionyl-amino acid derivatives and their use as beta-lactamase inhibitors
08/11/1999EP0934076A1 Solid phase lipoglycopeptide library, compositions and methods
08/11/1999EP0934073A1 Pharmaceutical composition, comprising complement proteins, for the treatment of helicobacter infections and a method for the preparation of the composition
08/11/1999EP0934067A1 Antimicrobial compositions
08/11/1999EP0934063A1 Use of antibodies to sialidase as anti-infectious agents and anti-inflammatory agents
08/11/1999EP0934040A1 Method for treating dementia due to aids
08/11/1999EP0933993A1 Substituted cyclopentane compounds useful as neuraminidase inhibitors
08/11/1999EP0827514B1 Heavy metal salts of succinic acid hemiesters with hyaluronic acid, or hyaluronic acid esters, a process for their preparation, and relative pharmaceutical compositions
08/11/1999EP0791007B1 Antifungal sordaridin derivatives
08/11/1999EP0789706A4 Sugar modified nucleosides and their use for synthesis of oligonucleotides
08/11/1999EP0755403B1 Method of separating protective components of bordetella pertussis
08/11/1999EP0734249B1 Novel and improved aminoglycoside formulation for aerosolization
08/11/1999EP0725651B1 Hemoregulatory peptides
08/11/1999EP0701572B1 Composite synthetic peptide construct eliciting neutralizing antibodies and cytotoxic t lymphocytes against hiv
08/11/1999EP0671904B1 Antibiotic formulation and use for bacterial infections
08/11/1999EP0651609B1 Pasteurella multocida toxoid vaccines
08/11/1999EP0646132B1 Amino sugars, glycoproteins, method of preparing them, medicines containing them and their use
08/11/1999EP0566666B1 Novel glucohydrolase inhibitors useful as antidiabetic antivital and antimetastatic agents
08/11/1999CN1225685A Avian polynucleotide vaccine formula for anti birds' disease
08/11/1999CN1225684A Avian polynucleotide vaccine formula for anti pig's diseases
08/11/1999CN1225653A Antiviral linear polymer
08/11/1999CN1225639A Phosphinate based inhibitors of matrix metalloproteases
08/11/1999CN1225637A Pyrrole triazines and pyrimidines
08/11/1999CN1225621A Inhibition of matrix metalloproteases by substituted biaryl oxobutyric acids
08/11/1999CN1225590A Peptides with increased binding affinity for HLA molecules
08/11/1999CN1225587A Compositions comprising an HIV protease inhibitor such as VX 478 and a water soluble vitamin E compound such as vitamin E-TPGS
08/11/1999CN1225585A 抗微生物组合物 The antimicrobial composition
08/11/1999CN1225556A Animal feed
08/10/1999US5936128 5,6-dihydropyrone derivatives as protease inhibitors and antiviral agents
08/10/1999US5936074 Reacting teicoplanin with echinocandin beta deacylase, then forming salt and/or deprotecting amino group; bactericides against gram-positive bacteria
08/10/1999US5936001 Stable buffering system; for sterilizing medical equipment
08/10/1999US5935998 Use of all allylamine derivatives such as terbinafine, in the manufacture of a medicament for the treatment of helicobacter pylori infection or associated diseases
08/10/1999US5935988 Mixtures of 2-amino-4-methylenecyclopentanecarboxylic acid with isoleucine, alanine or proline
08/10/1999US5935982 Methods of treating retroviral infection and compounds useful therefor
08/10/1999US5935976 Viricides, hiv
08/10/1999US5935957 Compounds, compositions and methods for treating influenza
08/10/1999US5935955 Substituted 3,6-dibenzylidene-2,5-piperazinediones, modulators of multidrug resistance
08/10/1999US5935950 Cephalosporin pyridinium derivatives
1 ... 1501 1502 1503 1504 1505 1506 1507 1508 1509 1510 1511 1512 1513 1514 1515 1516 1517 1518 1519 1520 1521 ... 1798